Prenatal diagnosis of trisomy 20 mosaicism by maternal serum screening for Down syndrome

Author(s):  
Jen-Huang Chen ◽  
Te-Yao Hsu ◽  
Chia-Yu Ou ◽  
Lih-Feng Chang ◽  
Shiuh-Young Chang ◽  
...  
2003 ◽  
Vol 23 (4) ◽  
pp. 331-335 ◽  
Author(s):  
Fran�oise Muller ◽  
Sophie Dreux ◽  
Henry Dupoizat ◽  
Serge Uzan ◽  
Marie-Fran�oise Dubin ◽  
...  

2007 ◽  
Vol 27 (3) ◽  
pp. 197-205 ◽  
Author(s):  
Romain Favre ◽  
Nathalie Duchange ◽  
Christophe Vayssière ◽  
Monique Kohler ◽  
Nicole Bouffard ◽  
...  

1995 ◽  
Vol 7 (6) ◽  
pp. 1413 ◽  
Author(s):  
KJ Powell ◽  
JG Grudzinskas

Second-trimester maternal serum screening for Down syndrome is now well established, and permits detection of up to 70% of cases. The disadvantage of this sort of screening is that the timing of maternal blood sampling is relatively late (after 15 weeks). There is an accumulating body of evidence to suggest that in the first trimester concentrations of a number of pregnancy-associated proteins and hormones differ in chromosomally normal and abnormal pregnancies. A first-trimester maternal serum screening test for Down syndrome may therefore be possible. In addition, new methods of screening have recently been described based on ultrasound findings at 11 to 13 weeks of gestation. This review article presents a discussion of published data on the feasibility of first-trimester screening for Down syndrome.


1996 ◽  
Vol 16 (5) ◽  
pp. 437-442 ◽  
Author(s):  
G. C. M. L. CHRISTIAENS ◽  
A. M. HAGENAARS ◽  
C. AKKERMAN ◽  
H. F DE FRANCE

2001 ◽  
Vol 21 (7) ◽  
pp. 553-557 ◽  
Author(s):  
Richard G. Ryall ◽  
David Callen ◽  
Robert Cocciolone ◽  
Amra Duvnjak ◽  
Renata Esca ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document